EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

de novo metastases in patients with primary colorectal cancer: a Surveillance, Epidemiology, and End Results analysis

Nicole C Loroña, Kamya Sankar, Mariana C Stern, Stephanie L Schmit, Jane C Figueiredo

Cancer Causes & Control · 2025

DOI: 10.1007/s10552-025-02002-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Causes & Control, 2025. Verfasst von Nicole C Loroña und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, 700 N. San Vicente Blvd. Suite G599, West Hollywoo…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Lung Neoplasms, Liver Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Nearly one-quarter of colorectal cancer (CRC) cases present with de novo metastatic disease (stage IV) at diagnosis. Some metastatic sites confer poorer prognosis, and emerging data suggests that individuals from certain racial and ethnic populations may be at higher risk for de novo metastases.

Methods

We identified 181,083 CRC cases aged 20–84 between 2010 and 2020 in the Surveillance, Epidemiology, and End Results database. Two outcomes were analyzed: metastatic site (liver, lung, bone, brain) and metastatic pattern (liver only, lung only, liver and lung, other). We used logistic and multinomial logistic regression to calculate odds ratios (OR) and 95% confidence intervals (95% CI) to examine the associations between race and ethnicity and metastatic site and metastatic pattern, respectively, among early-onset (age < 50), screen-eligible (age 50–74), and elderly populations (age 75–84).

Results

43,054 de novo metastatic CRC cases were identified over the 10-year period. Liver was the most common metastatic site (80%). Non-Hispanic Black patients had higher odds of synchronous lung and liver metastases compared to non-Hispanic White (NHW) patients (early-onset patients: OR: 1.29, 95% CI 1.03–1.61; screen-eligible patients: OR:1.42, 95% CI 1.29–1.55; elderly patients: OR:1.66, 95% CI 1.34–2.05). Early-onset American Indian/Alaska Native patients were over twice as likely to present with lung metastases (OR: 2.10, 95% CI 1.11–3.98) compared to NHW patients.

Conclusions

Presentation and patterns of de novo metastatic CRC differed across populations and age groups. Characterizing de novo metastatic CRC provides a unique opportunity to study cancer spread in treatment-naïve individuals and to identify patients at greater risk of metastases associated with poorer prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLung NeoplasmsLiver NeoplasmsHumansMiddle AgedAgedFemaleMaleSEER ProgramAdultAged, 80 and overYoung AdultUnited StatesNeoplasm MetastasisPrognosis

Stichwörter der Autor:innen

Colorectal cancerDisparitiesEarly-onsetEthnicityMetastaticRace

Autor:innen und Institutionen

  • Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, 700 N. San Vicente Blvd. Suite G599, West Hollywood, Los Angeles, CA, 90069, USA. Nicole.Lorona@cshs.org.
  • Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, 700 N. San Vicente Blvd. Suite G599, West Hollywood, Los Angeles, CA, 90069, USA.
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
  • Department of Computational Biomedicine, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIH
  • Cedars-Sinai Medical Center

Zitieren

APA

Loroña, N. C., Sankar, K., Stern, M. C., Schmit, S. L., & Figueiredo, J. C. (2025). de novo metastases in patients with primary colorectal cancer: a Surveillance, Epidemiology, and End Results analysis. Cancer Causes & Control. https://doi.org/10.1007/s10552-025-02002-6

Vancouver

Loroña NC, Sankar K, Stern MC, Schmit SL, Figueiredo JC. de novo metastases in patients with primary colorectal cancer: a Surveillance, Epidemiology, and End Results analysis. Cancer Causes & Control. 2025. doi:10.1007/s10552-025-02002-6

BibTeX
@article{Loroa2025,
  author = {Loroña, Nicole C and Sankar, Kamya and Stern, Mariana C and Schmit, Stephanie L and Figueiredo, Jane C},
  title = {de novo metastases in patients with primary colorectal cancer: a Surveillance, Epidemiology, and End Results analysis},
  journal = {Cancer Causes & Control},
  year = {2025},
  doi = {10.1007/s10552-025-02002-6}
}
Kostenlos starten →